The growing needs for analytical devices requiring smaller sample volumes, decreased power consumption and improved performance have been driving forces behind the rapid growth in nanomaterials research. Due to their dimensions, nanostructured materials display unique properties not traditionally observed in bulk materials. Characteristics such as increased surface area along with enhanced electrical/optical properties make them suitable for numerous applications such as nanoelectronics, photovoltaics and chemical/biological sensing. In this review we examine the potential that exists to use nanostructured materials for biosensor devices.
Introduction
Investment in nanomaterials research has grown exponentially over the last number of years. This is due to the huge range of opportunities afforded by nanomaterials in areas such as clean energy (for example solar panels and hydrogen storage), environmental monitoring (sensors for harmful chemicals or biological agents), improved materials (such as stronger/lighter plastics and antimicrobial surfaces), and new products (for example nanoscale transistors). It is clear that nanotechnologies come with the potential to drive economic growth, hence in 2000 the US government set up the National Nanotechnology Initiative and since then investment has grown annually ( Figure 1 ). The investment by NNI member agencies for 2011 is nearly $1.8 billion (http://www.nano.gov/). Currently most commercial success has resulted from the incorporation of nanomaterials into composites for reinforcement. This improves the strength of materials which can typically be used in products such as sports equipment (for example Babolat tennis rackets). Nanomaterials are also of interest for a number of other applications such as nanoelectronics (IBM and Intel both have active nanomaterials research programs). It is clear that nanotechnology will feature in many future products. Here we focus on the potential they offer for developing improved biosensors.
Nanomaterials are defined as matter with dimensions between 1 and 100 nm ( Figure   2 ). To put this into perspective, a sheet of paper is about 100,000 nanometers thick whereas a single gold atom is about a third of a nanometer in diameter. Nanomaterials therefore are larger than individual atoms/molecules but smaller than bulk materials, and thus have characteristic properties that neither completely obey quantum-nor classical-physics. Nanoparticles can be zero-, one-, or two-dimensional. The low dimensionality of nanoparticles results in large surface-to-volume ratios, and enhanced electronic and optical properties when compared with bulk samples of the same material. They are of interest for numerous applications including sensing, where the large surface area of nanomaterials specifically facilitates interaction with an increased number of target molecules when compared to their bulk counterparts (1) (2) (3) (4) (5) . Their small size is also responsible for superior electronic and optical properties which, due to quantum confinement effects, are very sensitive to minor perturbations.
Thus nanomaterials can be used to facilitate label-free detection, and develop biosensors with enhanced sensitivities and improved response times. The use of nanoparticles in biosensors is increasing due to this enhancement in sensitivity (as seen in Table 1 ), which is of major importance for clinical diagnostics as the concentration of targets can be very low in biological samples. A good example of this is DNA sensors which generally rely on polymerase chain reaction (PCR) for signal amplification. By developing biosensors with improved sensitivity it will eliminate the need for PCR and thus simplify DNA biosensors. This can be achieved using nanomaterials which, due to their large surface area, allow a greater number of DNA strands to be immobilised (6) . Nanomaterials can be incorporated into many types of biosensor configurations to develop magnetic, optical, electrical or electrochemical biodevices for the detection of many biological molecules including nucleic acids, antibodies, proteins, toxins and bacteria (7) (8) (9) (10) (11) (12) (13) The first biosensors were reported in the early 1960's, where a pH response for a 10 mg per cent solution of glucose was reported (14) . Since then there have been many advances made in the field, and devices are now more sensitive and more portable. In general, a biosensor can be described as a device which has a biological sensing element connected to (or integrated with) a transducer, thus transforming a biological event into a signal which can then be interpreted. The recognition biomolecule within a biosensor is highly selective, and can be immobilised by physical adsorption, entrapment or covalent attachment (8, (15) (16) (17) (18) . The sensitivity of a biosensor is dependent on the number and accessibility of recognition biomolecules present.
Nanomaterials enable the development of improved biosensors because they allow for incorporation of a greater number of recognition biomolecules which are more readily accessible to the target species, owing to greater porosity and surface area. Nanomaterials thus typically enable lower detection limits and faster response times, they can also enable label-free detection which is a major advantage (19, 20) . Many types of nanomaterials are suitable for biosensor applications including metallic nanoparticles (such as gold), magnetic nanoparticles (such as iron oxide), semiconducting nanoparticles (such as quantum dots and silicon nanowires), and organic nanoparticles (such as conducting polymers, carbon nanotubes) (13, (20) (21) (22) (23) (24) (25) .
Organic materials are more likely to be biocompatible and in this review article we will consider only organic nanomaterials, in particular we review conducting polymer nanostructures (CPs) and carbon nanotubes (CNTs).
Nanomaterials

Carbon Nanotubes
Carbon nanotubes (CNTs), discovered by Iijima in 1991 (26) , are an allotrope of carbon comprised of graphene sheets rolled up into cylinders of sp 2 hybridized atoms.
CNTs exist as single-(SWNTs), double-(DWNTs) and multi-walled (MWNTs)
structures. MWNTs are essentially a number of concentric SWNTs and hence have a larger diameter ( Figure 3 ). The diameter for SWNTs is usually less than 2nm, whereas diameters for MWNTs range between 2-100 nm, depending on the number of shells present. CNTs are typically microns long but, tubes up to 4cm in length have been reported (27) . Combined with their narrow diameter, this leads to excellent material properties such as a high aspect ratio and large surface area. CNTs can be approximated to one-dimensional nanostructures, as a result (28).
The electrical properties of a CNT are determined by the tube helicity and diameter ( Figure 4 ) (8) . If a CNT is imagined as a rolled-up graphene sheet, the helicity of the tube depends on the angle at which it is rolled-up, and can be described by its chiral vector, C h = na 1 + ma 2 (where a 1 and a 2 are unit vectors of the hexagonal lattice and, n and m are integers) (28). The direction of C h is perpendicular to the axis of the nanotube. The chiral angle (θ), is the angle between vectors C h and a 1. The n, m and θ values for a particular CNT, determine the electronic behaviour of the tube. If n -m is a multiple of 3 the tube is metallic otherwise, the tube is semiconducting (28). This stipulates that one-third of all tubes are metallic with the remaining two-third semiconducting.
The exponential increase in CNT patents filed in recent years reflects the level of commercial interest. However, applications for CNTs are currently limited by the difficulties associated with purification and the lack of precise control over the properties (such as chirality) of CNTs produced. At the moment, production of exactly one type of CNT is limited to the number of walls on the CNT, with some (53, 54) . Biomolecules of interest, including antibodies, may subsequently be anchored to these biopolymers wrapped around the CNTs (55).
Conducting Polymer Nanostructures
CPs are of interest for biosensor applications as they can be interfaced with biomolecules for effective signal transduction. CPs can be tailored to create substrates with a high surface area, controllable morphology and conductivity. These properties make them excellent transducer materials which can facilitate rapid electron transfer between immobilised biomolecules and an electrode surface (56) . Like metals/semiconductors, CPs can conduct charge carriers such as holes and electrons.
Unlike metals/semiconductors however they are low cost, and can be easily prepared and modified (57) . In 1977 Alan Heeger, Alan, MacDiarmid and Hideki Shirakawa discovered that when polyacetylene was exposed to bromine vapours, its conductivity rose by seven orders of magnitude (58) . Polyacetylene is a π-conjugated polymer meaning there are alternating single and double bonds along the polymer backbone. In a conjugated polymer the π-electrons can become delocalised and shared along the polymer chain, enabling them to conduct electricity. CPs are extremely useful as they combine the electrical properties of a metal with the low density and cost of a polymer. Potential applications include light emitting diodes, photovoltaics, electostatic discharge coatings and printable electronics (59) (60) (61) (62) . The conductivity of a CP is however sensitive to its chemical environment and can be varied over ten orders of magnitude (ranging typically from 10 -10 S/m to 10 0 S/m). This change in conductivity results from a change in the bonding structure, and is accompanied by a change in the colour/spectroscopy of the material (63) . Hence CPs are suitable for developing amperometric, potentiometric, conductometric, electrochemical, optical, calorimetric and piezoelectric biosensors (56) .
Certain CPs, such as polyacetylene, however are unstable thus limiting them from use in practical applications. CPs such as polyaniline (PAni), polypyrrole, polythiophenes and poly-ethylene-dioxythiophene (PEDOT) have greater stability and are more commonly investigated ( Figure 6 ). PAni, for example, switches between a non-doped insulating emeraldine base form and a doped conducting emeraldine salt form ( Figure   7 ). Switching is reversible and accompanied by a colour change from purple to green.
In the conductive form, delocalised electrons (called bipolarons) form along the polymer backbone and are responsible for charge transfer. A disruption in the conjugation of the polymer backbone results in a decrease in conductivity of the material, making it suitable for sensing applications. As PAni conductivity relies on protonation of the polymer by acid molecules, it's conductivity tends to be poor in solutions at neutral pHs (64) . This can be dealt with by covalently attaching acid molecules to CP backbones, resulting in a self-doping polymer (65, 66) .
The conductivity of a CP is always dependant on its oxidation state, and short term redox stability is a limitation which all unmodified CPs suffer from. CPs also tend to suffer from poor mechanical properties, for example polyprrole has been reported to have poor ductility, and is brittle (67) . Therefore, although CP films can be cast onto substrates, it is not generally possible to produce robust CP films with sufficient mechanical integrity to be free-standing. The mechanical properties of CPs can however, be improved by incorporating materials such as CNTs for reinforcement (68) . CPs also tend to have poor solubility in common solvents and are typically hydrophobic (69) . Large CP particles tend to agglomerate resulting in poor dispersions which are difficult to process. Using the nano-(versus bulk-) form of CPs however, tend to produce more stable homogenous dispersions. Stable aqueous colloids of PAni nanofibres have been produced without the need for surfactant stabilisation (70) .
For sensing applications, the response time and sensitivity of detection is also improved for the nano-versus the bulk-form of the material ( Figure 7 ). This is due to the increased number of reaction sites available for interaction with a target species 
Biosensing
Central to much sensor research is the ability to monitor biomarkers (in particular disease biomarkers) in 'real-time', with high sensitivity and selectivity in real untreated samples. This demand for sensitive, rapid, 'on-site' biosensor techniques has taken advantage of the latest advances in nanotechnology. To improve sensitivities, intense research has been carried out in signal amplification by nanomaterials.
CNTs
CNT-Electrical sensors
The oldest and most commonly used transducers in biosensors are electrochemical.
Electrical detection methods are appealing because of their low cost, low power consumption, ease of miniaturization, and potential multiplexing capability (81, 82) .
Due to their size and electronic properties, CNTs can be used to develop highly sensitive and specific nanoscale biosensors (83) (84) (85) . Challenges remain however in creating macro-sized structures that fully utilise the properties of the individual CNT nanocomponents. Three approaches to the development of electrochemical biosensors using CNTs dominate the literature ( Figure 8 ) (86, 87 give the best performance. However, the fabrication and manipulation challenges involved will limit its practical use. were reported in the early 60's, it has become one of the most frequently performed routine analyses in medicine. It is thus hardly surprising that an enormous amount of literature exists on glucose biosensors and more recently CNT-based glucose biosensors, which are covered in some recent reviews (94-97). Here we will highlight some general characteristics of these biosensors and present a few pertinent examples.
An example of a CNT-mat amperometric biosensor incorporated dispersed SWNTs with the enzyme glucose oxidase into redox polymer hydrogels (63) . These enzymatic redox composite films resulted in up to a 10-fold increase in the oxidation and reduction peak currents, while the glucose electro-oxidation current was increased 3-fold for glucose sensors. CNT-mat electrodes do not seem to provide significant advantages in reversibility or signal-to-noise ratio compared to the best redox protein films on conventional electrodes except in a few special cases (e.g. glucose oxidase) (98) . Rubianes and Rivas (99) showed how using dispersed CNTs allowed the development of highly sensitive glucose biosensors without redox mediators, metals or anti-interferent layers. The sensitivity of the CNT-mat electrode was 43 times higher than that obtained with the control graphite composite electrode, with a clinically relevant linear range and negligible interference from ascorbic acid (AA), uric acid (UA) and acetaminophen; all common blood interferents.
Even though the nanodimensions of CNTs makes them amenable to close contact with the redox active centres of proteins and enzymes, Gooding and co-workers have demonstrated that CNTs may not fully probe the protein active site (44) . In an interesting paper they describe how a self-assembled aligned shortened CNT forest probes the redox active centre of glucose oxidase, flavin adenine dinucleotide (FAD).
In one experiment they conjugated glucose oxidase directly to the ends of the shortened CNTs in the aligned forest. They compared its electrochemistry to that of an array conjugated to the enzyme active centre, FAD, with subsequent enzyme reconstitution around the CNT-immobilized FAD. They found that the latter approach allowed for more efficient electron transfer to the glucose oxidase active centre. 
CNT-FETs
In addition to electrochemical sensors using CNTs as an electrode substrate, sensors based on transistor arrangements using CNTs have been developed (113) . 
CNT-Optical sensors
Individual semiconducting SWNTs exhibit photoluminescence, with discrete bands in the near-infrared region between 900 and 1600nm. Since biologically relevant samples such as blood and tissue have low absorption in this region, the sharp nanotube fluorescence spectra may be detected even in a complex biological environment. Such semiconducting SWNTs were used as near-IR fluorescent tags for cell imaging and to selectively probe cell surface receptors (123) . The nanotubes were first non-covalently functionalised with amine groups using the surfactant PL-PEG- the glucose concentration and maintain that this type of sensor, enveloped in a small dialysis capillary, could be implanted in the body. The capillary could allow glucose to diffuse in, easily allowing sugar levels to be measured. This research demonstrates the feasibility of using CNT sensor systems in implantable biomedical sensors.
CPs
CP-Electrochemical sensors
An L.O.D. of 3.4 x 10 -10 mol/L was reported for a simple electrochemical oligonucleotide (ODN) sensor made using PAni nanotubes (125) . Solutions used during PAni synthesis contain polymeric acid (polymethyl vinyl ether-alt-maleic acid), and hence nanotubes have residual carboxylic acid functionalities which can be used to covalently graft ODN via carbodiimide chemistry. The authors report that they expect to achieve an even lower detection limit by optimizing the nanotube surface area. PAni nanowires can also be synthesised electrochemically, and subsequently modified with oligonucleotides via EDC coupling between phosphate groups and the amino groups of PAni (126) . Using this method the complimentary DNA target could be detected down to a concentration of 1 x 10 -12 mol/L. DNA-functionalised polyaniline nanofibres (100nm diameter) can also be used to specifically detect Gonorrhea. Up to 0.5 × 10 −15 M of complementary target could be detected by differential pulse voltammetry within 60 seconds of hybridisation (127) . These electrodes are found to be highly specific to distinguish the presence of N.
gonorrhoeae from N. meningitidis and other Gram-negative bacteria, (such as E. coli).
The performance of this STD sensor in clinical samples is being explored by the authors, and findings are expected to also have implications in relation to the clinical diagnosis of other sexually transmitted diseases.
CPs can also be used to detect many other targets for example, Dhand et al. report an electrode biosensor where cholesterol oxidase (ChOx) is covalently immobilised onto nano-structured PANI on indium tin oxide (ITO). Using this set-up good selectivity can be achieved and it is significant that interferants such as AA, UA, glucose, lactic acid, sodium pyruvate and urea were found to have a negligible effect on the sensor.
ChOx/PANI/ITO electrodes retain about 85% activity after 11 weeks (when stored at , with a detection limit of ~0.3 µM. This biosensor can be stored and re-used for up to one month without any loss in sensitivity. A similar biosensor of PTCA nanoparticles was used to covalently immobilise glutamate oxide. Glutamate concentrations could be determined, and an LOD of 0.1µM was reported for an in vitro measurement (wherein the biosensor was implanted into a rat's brain).
Polypyrrole is another example of a CP which can be used in the nanoform for low L.O.D biomolecule detection. An example of this is where a pyrrole monomer and biomolecule receptor (avidin) were electropolymerised within 100 nm wide channels (130) . When exposed to biotin−DNA, the conducting polymer nanowires generated a rapid change in resistance, with sensitivity as low as 1 nM. The method described offers advantages of direct incorporation of functional biological molecules into the conducting-polymer nanowire during its synthesis, site-specific positioning, built-in 
CP-Optical sensors
As well as electrochemical detection, nanostructured CPs can also be used for the optical detection of biomolecules. An example of this is where functionalised silicaPPy nanocomposites were used to detect anti-HSA. Flocculation of the nanocomposite dispersion occurs upon anti-HSA binding and the system can therefore be used for visual diagnostic assays (132) . Human serum albumin (HSA) is of interest as a target as it was previously used to detect renal disease. In another example of a HSA biosensor, pyrrole-propylic acid nanowires can be synthesized electrochemically via a templated method and subsequently modified using EDC crosslinker to covalently bind anti-HSA. Using this as a platform, HSA can then be detected using optical or electrical methods. Using an FET configuration nanomolar levels of HSA were reported (133).
Composites
By using nanostructured (versus bulk) materials, it is possible to develop biosensors which exhibit higher signal-to-background ratios, shorter response times, higher sensitivities and greater selectivity than previous biosensor configurations. Many different nanostructured geometries can be used to develop biosensors with improved sensing capabilities. However, it is interesting to also consider hybrid composites composed of two or more materials (134) . Using this approach the advantageous properties of each constituent can be exploited. CNT and CPs can be combined together (and also with other materials) to produce improved biosensors (19, 135) . In general the incorporation of CNTs tend to improve the sensitivity and selectivity of a biosensor (69) .
Composites can be used to improve the selectivity of biosensors, for example in 
Conclusion and Outlook
A key aspect in biosensor development still remains the integration of the electrical component with the biological recognition molecule. (96) . Quantum effects play a significant role in the behaviour of nanomaterials and can lead to novel optical, electrical and electrochemical properties.
Careful engineering of materials at the nanoscale means that their small size and novel characteristics can be exploited for practical bio-applications. Physical and chemical properties of materials, such as colour, and ability to conduct charge, are different at the nanoscale making it possible to achieve a number of improvements over more traditional bulk substrates.
The use of hybrid nanomaterials is becoming increasingly popular as it offers the opportunity to combine the advantageous properties of each individual constituent in a single composite material (140) . Composites are suitable for multiplexed biosensing enabling the detection of multiple analytes using a single assay. The signal to noise ratio could be further improved using a combination of optimised nanomaterials and advanced circuitry. It is also interesting to consider the idea of personalised healthcare whereby wearable sensors are becoming increasingly important (141) . Many challenges still remain in this area including the miniaturisation of integrated sensors and also issue of power supply. Thus as we have described, a wide range of nanomaterials and detection mechanisms are suitable for biosensing. The high surface area, porosity, and unique properties of nanomaterials facilitate the ultimate aim of a biosensor to achieve a significantly lower limit of biomolecule detection. The development of nanostructured biosensors is critical for further advancing the field of medical diagnostics. Therefore, the importance of nanomaterials for biosensor development cannot be overstated. 
